PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Light-emitting bioprobe fits in a single cell

Stanford nanoscale laser/LED marks a new age in the study and influence of living cells

Light-emitting bioprobe fits in a single cell
2013-02-14
(Press-News.org) If engineers at Stanford have their way, biological research may soon be transformed by a new class of light-emitting probes small enough to be injected into individual cells without harm to the host. Welcome to biophotonics, a discipline at the confluence of engineering, biology and medicine in which light-based devices – lasers and light-emitting diodes (LEDs) – are opening up new avenues in the study and influence of living cells.

The team described their probe in a paper published online February 13 by the journal Nano Letters. It is the first study to demonstrate that sophisticated engineered light resonators can be inserted inside cells without damaging the cell. Even with a resonator embedded inside, a cell is able to function, migrate and reproduce as normal.

APPLICATIONS AND IMPLICATIONS

The researchers call their device a "nanobeam," because it resembles a steel I-beam with a series of round holes etched through the center. These beams, however, are not massive, but measure only a few microns in length and just a few hundred nanometers in width and thickness. It looks a bit like a piece from an erector set of old. The holes through the beams act like a nanoscale hall of mirrors, focusing and amplifying light at the center of the beam in what are known as photonic cavities. These are the building blocks for nanoscale lasers and LEDs.

"Devices like the photonic cavities we have built are quite possibly the most diverse and customizable ingredients in photonics," said the paper's senior author, Jelena Vuckovic, a professor of electrical engineering. "Applications span from fundamental physics to nanolasers and biosensors that could have profound impact on biological research."

At the cellular level, a nanobeam acts like a needle able to penetrate cell walls without injury. Once inserted, the beam emits light, yielding a remarkable array of research applications and implications. While other groups have shown that it is possible to insert simple nanotubes and electrical nanowires into cells, nobody had yet realized such complicated optical components inside biological cells.

"We think this is quite a dramatic shift from existing applications and will enable expanded opportunities for understanding and influencing cellular biology," said the paper's first author Gary Shambat, a doctoral candidate in electrical engineering. Shambat works at the Nanoscale and Quantum Photonics Lab directed by Vuckovic.

IRON TO A MAGNET

In this case, the studied cells came from a prostate tumor, indicating possible application for the probe in cancer research. The primary and most immediate use would be in the real-time sensing of specific proteins within the cells, but the probe could be adapted to sense any important biomolecules such as DNA or RNA.

To detect these key molecules, researchers coat the probe with certain organic molecules or antibodies that are known to attract the target proteins, just like iron to a magnet. If the desired proteins are present within the cell, they begin to accumulate on the probe and cause a slight-but-detectable shift in the wavelength of the light being emitted from the device. This shift is a positive indication that the protein is present and in what quantity.

"Let's say you have a study that is interested in whether a certain drug produces or inhibits a specific protein. Our biosensor would tell definitively if the drug was working and how well based on the color of the light from the probe. It would be quite a powerful tool," explained Sanjiv Sam Gambhir, MD, co-author of the paper and chair of the Department of Radiology at the Stanford School of Medicine as well as director of Stanford's Canary Center for Early Cancer Detection.

As such, embeddable nanoscale optical sensors would represent a key development in the quest for patient-specific cancer therapies—often referred to as personalized medicine—in which drugs are targeted to the patient based on efficacy.

A CLEVER STRUCTURE

Structurally, the new device is a sandwich of extremely thin layers of the semiconductor gallium arsenide alternated with similarly thin layers of light-emitting crystal, a sort of photonic fuel known as quantum dots. The structure is carved out of chips or wafers, much like sculptures are chiseled out of rock. Once sculpted, the devices remain tethered to the thick substrate.

Shambat and his fellow engineers have been working on similar optical devices for use in ultrafast, ultra-efficient computer applications where having devices immobilized on chips and wafers does not matter so much since they will ultimately be integrated with microelectronics.

For biological applications, however, the thick, heavy substrate presents a serious hurdle for interfacing with single-cells. The underlying and all-important nanocavities are locked in position on the rigid material and unable to penetrate cell walls.

Shambat's breakthrough came when he was able to peel away the photonic nanobeams, leaving the bulky wafer behind. He then glued the ultrathin photonic device to a fiber optic cable with which he steers the needle-like probe toward and into the cell.

Similarly, anticipating that gallium arsenide could be toxic to cells, Shambat also devised a clever way to encapsulate his devices in a thin, electrically insulating coating of alumina and zirconia. The coating serves two purposes: it both protects the cell from the potentially toxic gallium arsenide and protects the probe from degrading in the cell environment.

"STUNNING" RESULTS

Once inserted in the cell, the probe emits light, which can be observed from outside. For engineers, it means that almost any current application or use of these powerful photonic devices can be translated into the previously off-limits environment of the cell interior.

In one finding that the authors describe as stunning, they loaded their nanobeams into cells and watched as the cells grew, migrated around the research environment and reproduced. Each time a cell divided, one of the daughter cells inherited the nanobeam from the parent and the beam continued to function as expected.

This inheritability frees researchers to study living cells over long periods of time, a research advantage not possible with existing detection techniques, which require cells be either dead or fixed in place.

"Our nanoscale probes can reside in cells for long periods of time, potentially providing sensor feedback or giving control signals to the cells down the road," said Shambat. "We tracked one cell for eight days. That's a long time for a single-cell study."



INFORMATION:

Other contributing authors of the study include post-doctoral scholar Sri-Rajasekhar Kothapalli, research associate J Provine, doctoral candidate Tomas Sarmiento and Professor James Harris.

Funding for this study was provided by The Beckman Center for Molecular and Genetic Medicine at Stanford, the Canary Foundation and the Center for Cancer and Nanotechnology Excellence.

This article was written by Andrew Myers, associate director of communications for the Stanford University School of Engineering.


[Attachments] See images for this press release:
Light-emitting bioprobe fits in a single cell

ELSE PRESS RELEASES FROM THIS DATE:

Recent marijuana use in HIV-infected Russians associated with increased sex and drug risk behaviors

2013-02-14
(Boston) – Researchers from Boston Medical Center (BMC) and Boston University's School of Medicine (BUSM) and School of Public Health (BUSPH) have found that in Russian HIV-infected risky drinkers, marijuana use is associated with other increased risky behaviors involving drug use and sex. These findings, published online in the journal Drug and Alcohol Dependence, may aid clinicians and public health experts in detecting individuals at a higher risk of transmitting HIV. Marijuana, otherwise known as cannabis, is the most frequently used illicit drug worldwide. Previous ...

Team creates MRI for the nanoscale

Team creates MRI for the nanoscale
2013-02-14
Magnetic resonance imaging (MRI) reveals details of living tissues, diseased organs and tumors inside the body without x-rays or surgery. What if the same technology could peer down to the level of atoms? Doctors could make visual diagnoses of a person's molecules – examining damage on a strand of DNA, watching molecules misfold, or identifying a cancer cell by the proteins on its surface. Now Dr. Carlos Meriles, associate professor of physics at The City College of New York, and an international team of researchers at the University of Stuttgart and elsewhere have opened ...

Gene associated with high anxiety can have protective effect on the battlefield

Gene associated with high anxiety can have protective effect on the battlefield
2013-02-14
The onset of Post-Traumatic Stress Disorder (PTSD) is unpredictable. Because it depends on the unforeseeable occurrence of traumatic events, it is difficult to identify preventative or causative factors. Scientists typically turn to patients who have already developed PTSD to study the disorder, but that means they can't draw comparisons to their psychological state prior to experiencing trauma. Now, through a combination of genetic and psychological testing, Prof. Yair Bar-Haim and PhD student Ilan Wald of Tel Aviv University's School of Psychological Sciences have ...

2 NASA satellites see Cyclone Gino's 'centered' power

2 NASA satellites see Cyclone Ginos centered power
2013-02-14
Data from NASA's Aqua and Terra satellites showed powerful thunderstorms continued to wrap around the center of circulation Tropical Cyclone Gino as the storm achieved a category 2 hurricane status. The Atmospheric Infrared Sounder (AIRS) instrument that flies aboard NASA's Aqua satellite captured an infrared image of Cyclone Gino on Feb. 12 at 1935 UTC (2:35 p.m. EST). The AIRS temperature data showed Gino maintained a large area of powerful thunderstorms with cold cloud top temperatures and a band of strong thunderstorms wrapping in from the southeast. Cloud top temperatures ...

Stem cell source an important factor, impacting ability to treat myocardial infarction

2013-02-14
Putnam Valley, NY. (Feb. 13, 2013) – When a research team from Denmark and Sweden compared the therapeutic capabilities of adipose-derived stem cells (ASCs) versus bone marrow-derived stem cells (BMSCs) obtained from a single 84 year-old male donor with ischemic coronary disease to regeneratively treat myocardial infarction in a rat model, they found that the ASCs preserved more cardiac function in the test rats while neither stem cell type induced myocardial angiogenesis (blood vessel growth.) The study appears as an early e-publication for the journal Cell Transplantation, ...

Impact of stem cell transplantation location in brain a crucial factor for cell survival

2013-02-14
Putnam Valley, NY. (Feb. 13, 2013) – Researchers at the Johns Hopkins University in Baltimore, Md., and the Mossakowski Medical Research Centre in Warsaw, Poland, have found that nonself-donated cells (allografts) better survive implantation into the brains of immunocompetent research mice when the grafts are injected into the striatum (STR) of the brain rather than injected into the forceps minor (FM) region. In their study, all FM grafts were rejected while STR grafts accumulated and survived along the border between the striatum and the corpus callosum. "To the best ...

Drug shown to reverse radioiodine resistance in some advanced thyroid cancers

2013-02-14
NEW YORK, FEBRUARY 13, 2013 – The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan-Kettering Cancer Center. Published in the February 14 issue of the New England Journal of Medicine, the study offers new hope for patients with a disease that can have a poor prognosis. An estimated 56,000 new cases of thyroid cancer are diagnosed each year in the United States, and that number is on the rise, according ...

Study suggests link between untreated depression and response to shingles vaccine

2013-02-14
[EMBARGOED FOR FEB. 14, 2013] Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition caused by the reactivation of the varicella-zoster virus, and more than a million new cases occur each year in the U.S. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition. In a two-year study, led by Michael ...

A quantum dot energy harvester

2013-02-14
A new type of nanoscale engine has been proposed that would use quantum dots to generate electricity from waste heat, potentially making microcircuits more efficient. "The system is really a simple one, which exploits certain properties of quantum dots to harvest heat," Professor Andrew Jordan of the University of Rochester said. "Despite this simplicity, the power it could generate is still larger than any other nanoengine that has been considered until now." The engines would be microscopic in size, and have no moving parts. Each would only produce a tiny amount of ...

Daniel Brown, Dallas, TX Re-elected to Concierge PA Inc. Executive Board Named Chair of Non-profit, Charitable and Pro Bono Committee

2013-02-14
Concierge PA, Inc., a leading consultancy firm based in Dallas, Texas that specializes in providing cost-contained, top-tier strategic communications and employer/employee solutions to clients throughout North America, announced today that Daniel Brown was unanimously re-elected to its Board of Directors. The corporation also announced that Brown would chair its Non-profit, Charitable and Pro Bono Committee. A native of Louisiana and a long-term resident of Dallas, Mr. Brown brings a wealth of experience to the Executive Board of Concierge PA, Inc. A seasoned operations ...

LAST 30 PRESS RELEASES:

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

[Press-News.org] Light-emitting bioprobe fits in a single cell
Stanford nanoscale laser/LED marks a new age in the study and influence of living cells